See discussions, stats, and author profiles for this publication at: https://www.researchgate.

net/publication/266029486

Antibacterial Activities of Flavonoids: Structure-Activity Relationship and

Mechanism

Article  in  Current Medicinal Chemistry · September 2014

DOI: 10.2174/0929867321666140916113443 · Source: PubMed

CITATIONS READS
131 10,276

4 authors, including:

Yixi Xie Weijie Yang

Xiangtan University Zhoukou Normal University
43 PUBLICATIONS   572 CITATIONS    21 PUBLICATIONS   427 CITATIONS   

SEE PROFILE SEE PROFILE

Xiaoqing Chen
Central South University
163 PUBLICATIONS   3,382 CITATIONS   

SEE PROFILE

Some of the authors of this publication are also working on these related projects:

Study on the influence of glycation of serum albumin on the antioxidant activity and metabolism of dietary polyphenols View project

All content following this page was uploaded by Xiaoqing Chen on 24 January 2015.

The user has requested enhancement of the downloaded file.

Send Orders for Reprints to reprints@benthamscience.net
132 Current Medicinal Chemistry, 2015, 22, 132-149

Antibacterial Activities of Flavonoids: Structure-Activity Relationship and

Mechanism
Yixi Xie1, Weijie Yang1, Fen Tang1, Xiaoqing Chen1,2,*,# and Licheng Ren3,*
1
College of Chemistry and Chemical Engineering, Central South University, Changsha, 410083, China;
2
Collaborative Innovation Center of Resource-conserving & Environment-friendly Society and Ecological
Civilization, Central South University, Changsha, 410083, China; 3Department of Burns and Reconstruc-
tive Surgery, Xiangya Hospital, Central south University, Changsha, 410008, China
Abstract: Flavonoids are well known as antibacterial agents against a wide range of pathogenic microor-
ganism. With increasing prevalence of untreatable infections induced by antibiotic resistance bacteria, fla-
vonoids have attracted much interest because of the potential to be substitutes for antibiotics. In this re-
view, the structure-relationship of flavonoids as antibacterial agents is summarized, and the recent advancements on the
antibacterial mechanisms of flavonoids are also discussed. It is concluded that hydroxyls at special sites on the aromatic
rings of flavonoids improve the activity. However, the methylation of the active hydroxyl groups generally decreases the
activity. Besides, the lipopholicity of the ring A is vital for the activity of chalcones. The hydrophobic substituents such as
prenyl groups, alkylamino chains, alkyl chains, and nitrogen or oxygen containing heterocyclic moieties usually enhance
the activity for all the flavonoids. The proposed antibacterial mechanisms of flavonoids are as follows: inhibition of nu-
cleic acid synthesis, inhibition of cytoplasmic membrane function, inhibition of energy metabolism, inhibition of the at-
tachment and biofilm formation, inhibition of the porin on the cell membrane, alteration of the membrane permeability,
and attenuation of the pathogenicity.
Keywords: Antibacterial activity, flavonoids, mechanism, structure-relationship.
#
Author’s Profile: Xiaoqing Chen is a professor at Central South University, China. She obtained a Ph.D. in applied chemistry
at Central South University in 2003. Her major areas of research expertise and interest are including asymmetric synthesis,
chiral separation, separation of natural products; analytical nanotechnology; polyphenols.

1. INTRODUCTION Flavonoids are the primary class of polypehols with C6-

The emergence of drug-resistant bacteria has become the
major cause of failure in the treatment of infectious diseases
[1, 2]. It has been recently reported that 23,000 Americans
die of an untreatable bacterial infection due to antibiotic re-
sistance each year, and 25,000 deaths for EU per year [3].
Epidemiologic studies have revealed the elevating morbidity
and mortality rates of infectious diseases due to antibiotics
resistance [4-6]. The inefficacy of currently available antibi-
otics urges the searching for new type antibacterial agents
against the drug-resistant bacteria. Since the pharmaceutical
development has historically relied on natural products to
provide biological active compounds, screening for natural
antibacterial agents have been broadly studied, and even
become new leads for antibacterial drug discovery [7-9].
Currently, a wide range of phytochemicals have proven to be
potential antibacterial agents including terpenoids, essential
oils, alkoloids, lectins, polypeptides, phenolics, and poly-
phenols [10, 11]. Among these compounds, phenolics and
polypenols have attracted many interests of researchers for
their wide existence, low toxicity, and high activity against
drug-resistant bacteria such as methicillin-resistant Staphylo-
coccus aureus (MRSA) [12, 13].
*Address correspondence to these authors at the College of Chemistry and
Chemical Engineering, Central South University, Changsha 410083, P R
China; Tel: +86 (731) 8830833; E-mail: xqchen@mail.csu.edu.cn and De-
partment of Burns and Reconstruction Surgery, Xiangya Hospital, Central
south University, Changsha, 410008, P R China; Tel: +86 (731) 85295888;
Fax: +86(731)533525; E-mail: renlicheng@sina.com
C3-C6 skeleton. There have been over 8000 known flavon-
oid molecules until now [14]. Most of them have shown
multiple biological activities such as anti-oxidation, anti-
inflammation, anticancer and cardiovascular protection [15].
Flavonoids can be divided into several subclasses depending
on their oxidative status and substituents. The skeletons of
six common flavonoid subclasses with antibacterial activity
are shown in Fig. (1). The antibacterial activity of flavonoids
can be exerted in three ways: directly kill the bacteria, syner-
gistically activate the antibiotics, and attenuate the bacterial
pathogenicity [16]. It is worth mentioning that the flavonoids
have shown inhibitory activity against the efflux pump of
MRSA [17], and also restrained the synthesis of peptidogly-
can and ribosome in the cells of amoxicillin-resistant Es-
cherichia coli (AREC) [18]. They have also shown inhibi-
tory activity against different kinds of -lactamases produced
by bacteria which are the key enzymes that disable the com-
mon antibiotics [19-21]. The mechanisms for flavonoids as
antibacterial agents have been discussed in more detail by
Cushnie et al. [16, 22].
The antibacterial activity of flavonoids depends on the
structures, namely on the substitutions on the aromatic rings.
With the plant extract with antibacterial activities increas-
ingly being found, more and more flavonoids have proven to
be antibacterial agents, especially the ones with hydrophobic
substituents such as prenyl groups [23-26]. Some studies
have focused on the structure prerequisites for antibacterial
activity of flavonoids, but no reviews have been systemati-
cally documented the developments on the antibacterial

1875-533X/15 $58.00+.00 © 2015 Bentham Science Publishers

Antibacterial Activities of Flavonoids
B O
O CH
A *
A C
R B
O OH
O
Flavone, R=H Isoflavone, * as " "
Flavonol, R=OH Dihydroisoflavone, * as "
O
* O
R
O O
Flavanone, R=H
Chalcone, * as " "
Flavanonol, or
(Dihydroflavonol), R=OH Dihydrochalcone, * as "
Fig. (1). Structure skeletons of the major subclasses of flavonoids.
flavoniods. Besides, the antibacterial mechanism of flavon-
oids has also been continuously testified and renewed. Here
in, based on the previous reviews and the recent literatures,
the structure-activity relationship and the advancements in
understanding the mechanisms of flavonoids as antibacterial
agents have been reviewed.
2. ANTIBACTERIAL ACTIVITIES OF FLAVONOIDS
2.1. Flavone
Flavones have been widely investigated on their antibac-
terial activity. Sohn et al. [27], isolated two di-prenylated
flavones kuwanon C and morusin from medicinal plants, and
evaluated their antimicrobial activities using the broth micro
dilution methods. The former showed strong activities
against both gram negative bacteria (E. coli, S. typhimurium)
and gram positive bacteria (S. epidermis, S. aureus), while
the latter only showed limited activities against gram posi-
tive bacteria. Yin and coworkers [28] also isolated a mono-
prenylated flavone named corylifol C from the seeds of
Psoralea corylifolia, and found it was not effective to inhibit
the growth of Staphylococcus aureus and S. epidermidis in
vitro. These results indicate the importance of the degree of
prenylation for the antibacterial activity. The substitutive
prenyl group sometimes reacts with the adjective hydroxyl
group to form a heterocycle of six members, which probably
decrease the activity. For example, morusin has a C-3 prenyl
group and another C-8 prenyl group which forms a ring-
substituent with the hydroxyl group at C-7 position, and it
showed lower activity than kuwanon C (seen Fig. 2) [27].
Due to the planar structure of flavonoid skeleton, the geranyl
group at C-3 position of C ring is apt to crosslink with the
hydroxyl group at C-3 position of C ring, a case in the point
is the prenylated flavone (PF) isolated from a hybid of Arto-
carpus plants which showed strong antibacterial activity
against A. baumannii with MIC value of 50 g mL-1 [29]. In
addition to alkenyl substituted flavones, acyllated flavones
also have been evaluated on their antibacterial activities.
Babu and coworkers investigated the antibacterial activities
of 7-O-acyl derivatives of Oroxylin A and found the intro-
duction of acyl group at the C-7 position of Oroxylin A sig-
Current Medicinal Chemistry, 2015, Vol. 22, No. 1 133
O
O
O
Flavan-3-ols (catechin) Aorune
"
O
O
OH
O O
OH
R O
Proanthocyanidin Bioflavonoid
"
nificantly enhanced the antibacterial activity [30]. When the
acyl groups contained long chain alkyls or phenyls (Fig. 2),
the Oroxylin A derivatives even showed stronger antibacte-
rial activities than the other derivatives. More over, nitrogen-
containing flavone analogs have been increasingly prepared
and studied on their antibacterial potentials. Babu et al. [31],
synthesized a series of chrysin derivatives in which chrysin
ring system linked to the alkyl amines by different spacers at
C-7 position, and evaluated their antibacterial activities. All
the derivatives showed higher antibacterial effects than chry-
sin
and the ones with morpholine or N,N-dimethyl amine
substituents even inhibited the growth of the tested gram
positive bacteria with the same minimum inhibitory concen-
trations (MIC) as streptomycin. Similar results were obtained
in study by Zhu’s group which showed the compounds with
N-heterocyclic moieties at C-7 position of chrysin had a
much higher activity than other species [32]. Zhu’s group
also found that morpholine, benzylamine and their derivative
subsituents were favorable for the antibacterial activities of a
series of luteolin analogs [33]. Another study by Liu and
coworkers demonstrated that the modifications of apigenin at
8-C position by nitrogen-containing cyclic or aliphatic chain
substituents enhanced the antibacterial activities [34]. Nota-
ble among these apigenin analogs was the one with mor-
pholine substituent which had potent antibacterial activities
similar to those of tetracycline against gram-positive strains
S. aureus and B. subtilis.
2.2. Flavanone
Unlike flavone, flavanone has the saturated C3-C4 bond
of C ring which makes the nuclear skeleton of flavanone
non-planar (Fig. 3). Flavanones such as nobiletin, tangeretin
and liquiritigenin have been reported as the responsible ac-
tive agents for the antibacterial activity of some medicinal
plants [35-37]. The subsitutents significantly influence the
antibacterial activity of flavanones. Celiz et al., found the
attachment of a saturated aliphatic chain with 10-12 carbon
atoms to the sugar attached to the A ring of narigenin greatly
increased the anti-listerial and anti-staphylococcal activity
[38]. The mono or poly methoxylation of flavanone,
134 Current Medicinal Chemistry, 2015, Vol. 22, No. 1 Xie et al.

OH
HO OH
OH HO OH OCH3
O O
HO O HO O H3CO O
OH
O
OH O
O OH O OH O

Corylifol C Kuwanon C Morusin PF

OH
CH2R
HO O R O O N
ROCO O ( )n

H3CO N,N-Dimethyl amine

OH O
OH O OH O
R=Morpholinyl; R=-N(C2H5)2
R=-NH-C2H5 R=:
1.R=Ph H3CN N N O N
2.R=-(3,4,5-trimethoxy)phenyl R: N
3.R=(CH2)16CH3 NH
N-methyl piperazinyl Piperidinyl Morpholinyl
Pyrryl Cyclohexane amine
7-O-acyl derivatives of Oroxylin Apigenin analogs 7-O-alkylamino derivatives of chrysin

Fig. (2). Chemical structures of hydrocarbonyl substituted flavones.

A: B: C: COOR
3'
R1 R2 OH
R4 HO
HO
prenyl isoprenyl geranyl OH
HO O O O
* R3
D: E:
6'
6
OH O
R5 O lavandulyl lavandulyl in the limonene form
alkyl prunin esters:R=(CH2)1-16CH3
F:
farnesyl

Glabranine : R1=R2=R3=H,R5=OH, * =
OCH3
8-Prenylnaringenin : R1=R3=H, R2=R5=OH
a : R1=R2=R5=OH, R3=B, R4=A, * =
RO O
b : R1=OCH3, R2=R5=OH, R3=B, R4=A, * = HO OH OH
c : R1=OCH3, R2=R5=OH, R3=B, R4=A
Leachianone G : R1=R2=R5=OH,R3=H,R4=B O O
Kushenol R: R1=OH, R2=R3=R5=H,R4=D,* = OH O
Sophoraflavanone G :R1=R2=R5=OH,R3=H,R4=C
Kenusanone D :R1=R5=OH,R3=H,R2=OCH3,R4=A
R=CH3 or
Exiguaflavanone D:R1=R5=OH,R3=H,R2=OCH3,R4=D,6=A OH O
propolin I:R1=R3=R4=H, R5=R2=3'=OH,6=F -CH2(CH2)1~14CH3

Fig. (3). Structures of antibacterial flavanones.

however, hardly increased the antibacterial activity [39].
Manner et al., reported that 8-prenylnaringenin and another
8-prenylflavanone glabranine were highly active in inhibit-
ing the formation of S. aureus biofilms [40]. The flavanones
substituted by prenyl groups at 6-C or 8-C positions both
showed activity against S. aureus [41]. The prenylflavanones
even showed great activity against the biotic-resistant bacte-
ria, for ex., three prenyl substituted flavanones (Fig. 3, a,b,c)
isolated from the roots of Dalea scandens all exhibited sig-
nificant activity against both methicillin-susceptible and me-
thicillin-resistant S. aureus [42]. Table 3 summarized the
antibacterial activities of prenyl flavanones reported in litera-
tures. Besides of prenylflavanones, both geranyl and lavan-
dulyl flavanones have also proven to be active antibacterial
agents. Tsuchiya et al., investigated the activity of a series of
geranyl and lavandulyl flavanones against MRSA and found
all these flavanones were active anti-MRSA agents. Besides,
sophoraflavanone G with 6-lavandulyl group showed much
higher activity than leachianone G with 6-prenyl group, indi-
cating lavandulyl group was a more efficient moiety for en-
hancing antibacterial activity. In addition, exiguaflavanone D
with two subsitutents at 6-C and 8-C positions exhibited
higher activity than kenusanone D with only single 6-C sub-
situent [43]. As sum in Table 2B, the geranyl and lavandulyl
substituents were mostly appeared at C-6 and C-8 positions
of A ring, and also at 3
-C position of B ring in some cases.
For example, kenusanone A with and myrsininone B were
respectively substituted by geranyl group and lavandulyl
Antibacterial Activities of Flavonoids
group, which both showed potent antibacterial activities [43,
44]. More over
the substitutive group sometimes reacts
with the adjective hydroxyl group to form a heterocycle of
six member, for example, lupinifolin has a C-8 prenyl group
and another C-6 prenyl group which forms a ring-subsituent
with the hydroxyl group at C-7 position [45]. Similar hetero-
cyclic structures also appear in the C-6 geranyl groups of
both mimulone C nad mimulone D which had moderate ac-
tivity against S. aureus and some MRSA strains [46].
In addition to alkenyl substituted flavones, alkylated fla-
vones also have been evaluated on their antibacterial activi-
ties. Zhang and coworkers investigated the antibacterial ac-
tivities of 7-alkoxyhesperetin derivatives and found the anti-
bacterial effects increased with the elongating hydrocarbon
chains substituted for H at C-7 position of hesperetin [47].
When substituted by alkyls with 8-12 carbon atoms, the hes-
peritin derivatives even showed stronger antibacterial activi-
ties against gram-positive bacteria (B. subtilis and S. aureus)
than the positive control streptomycin sulfate in vitro.
2.3. Flavonol and Dihydroflavonol
Compared with flavone, flavonol has an additional hy-
droxyl group at C-3 position, and when the C3-C4 double
bound is saturated, it turns into dihydroflavonol. Flavonols
have been reported to be active agents against both gram-
negative and gram-positive microorganisms, but the fla-
vonols with only hydroxyl or methoxyl substitutions gener-
ally show activity that is rather weaker than common antibi-
otics [48-50]. For example, kaempferol showed activity
against S. aureus and E. coli, and the MIC values was re-
spectively 63 and 16 g mL-1, while those values of gen-
tamicin (antibiotic) was only 0.2 and 0.8 g mL-1, corre-
spondingly [51]. However, hydrocarbonyl substitutions have
significantly enhanced the antibacterial activity of flavanols
and dihydroflavonols. Prenyl group is the most common
subsitutent for flavonol derivates. As tested by Sohn et al.,
the 6,5-diprenyl substituted flavanol papyriflavonol A ex-
hibited the most potent antibacterial activity among the 18
HO OH
HO
HO O OR1
OH
O OH
OH
Papyriflavonol A Stenopalustroside-
HO OR4
R2
HO O a: HO
R3
R1 OH b:
OH O H
c:
Kenusanone C:R1= geranyl, R2= prenyl,
R3=OH,R4=CH3
Kushenol X :R1=R3=R4=H,R2= lavandulyl
Fig. (4). Antibacterial flavonols and dihydroflavonols.
Current Medicinal Chemistry, 2015, Vol. 22, No. 1 135
prenylated flavonoids isolated from several medicinal plants,
and another dihydroflavanol kenusanone C with 6-geranyl
and 8-prenyl substitutions also showed potent activity [27].
In addition, 3-O-methyldiplacol with 6-geranyl group has
shown low MIC values of 2~4 g mL-1 against six gram-
positive bacteria [52], which has been verified by another
study that showed the MIC values of 4~8 g mL-1 for the
same dihydroflavonol against S. aureus and other four
MRSA strains [46]. Lavandulyl group is another prenyl
group which has appeared in kushenol X with MIC values of
10 g mL-1 against both S. aureus and B. subtilis [53]. The
prenyl group sometimes reacts with the adjacent hydroxyl
group to form a heterocyclic substituent which seems to be
favorable configuration for antibacterial activity. This was
supported by the result that lanneaflavonol and dihydrolan-
neaflavonol both showed great activity against S. aureus with
MIC values (about 2.0 g mL-1) close to ampicillin (about
1.5 g mL-1) [54]. More over, Sasaki et al. investigated sev-
eral prenylated dihydroflavanols on their anti MRSA activi-
ties, it was found that MRSA strains were sensitive to most
of the dihydroflavanols, and some flavonols with heterocyc-
lic substitutions on ring A even showed higher activity than
oxacillin [55]. According to the data summed in Table 3, the
dihydroflavanols generally exhibits better activity than
flavanols, and the compounds with double prenyl substitu-
ents are more active than the corresponding single substi-
tuted ones. The structures of the referred compounds are
shown in (Fig. 4).
2.4. Flavanols
Flavanols have been reported to exhibit several health
beneficial effects by acting as antioxidant, anticancer, cardio-
preventive, neuro-protective, antimicrobial, and anti-viral
agents [56]. Catechin (flavan-3ol) and its derivates are the
mostly studied monomeric falvanols with broad biological
activity [57]. Catechins are plentiful in tea leaves and have
been regarded as the ingredients responsible for the antimi-
crobial activity of tea extracts [58, 59]. The antimicrobial
HO OH OH
OCH3
O
O O
OH
O OH
O
O OH
OR2
O
A:R1=R2=a
B:R1=a, R2= c
Lanneaflavonol
C:R1=a, R2= b
D:R1=b, R2= a OH
OCH3
H H O
C C C
O O
H O OH
HO C C C
OH
H3CO
H O OH O
HO C C C
H Dihydrolanneaflavonol
136 Current Medicinal Chemistry, 2015, Vol. 22, No. 1 Xie et al.

activities of different types of tea and their polyphenols have lated a type A proanthocyanidin ( (+)-Epigallocatechin-
been recently reviewed by Bansal et al. [60]. It was con- (2O7,48)-(+)-catechin, EPA) along with some type
cluded that most of catechins and theaflavins showed anti- B proanthocyanidins such as procyanidin B3 (PB3) and
bacterial activity against the common pathogenic bacteria epicgallocatechin-(4-8)-catechin (PEC) from Quercus ilex
such as S. aureus, MRSA, E. coli, and H. pylori. It was also leaves, and demonstrated that EPA was an effective antibac-
suggested that the additional hydrophobic alkyl side chain terial agent against both gram-negative and positive bacteria
enhanced the antibacterial activity of EGCG because of in- with the MIC values of 0.08~0.17 mol mL-1 and MBC val-
creased membrane-permeability. However, a catechin de- ues of 0.17~0.17 mol mL-1, PB3 and PEC both showed
rivate isolated from Loropetalum chinense, named loropetal- antibacterial activities though weaker than EPA [69]. In ad-
iside A with a 1-(3,4-dihydroxyphenyl) 3-methoxy-3- dition, it has been reported that procyanidin B2 showed
oxopropyl substitutent at C-8 position showed no activity moderate activity against B. cereus with MIC value of 39.1
against the tested bacteria [61]. Besides, a partially additive g mL-1
although the activity against other panthogenic
growth inhibitory effect between catechin and gallic acid bacteria was quite limited [70]. Such limited antibacterial
against H. pylori was observed in the recent study [62]. The activity has also been observed for procyanidin A2 against B.
significant synergy between theaflavin and epicatechin subtilis [71]. Compared with dimmers, the avans trimmers
against clinical isolates of S. maltophilia and A. baumannii seem to have a little higher antibacterial activity, and the
was also observed in another study by Betts and coworkers oligomeric avanols generally showed higher activity than
[63]. the monomeric ones [71, 72]. The antibacterial activlity of
Proanthocyanidins are oligomers and polymers of avans hydrocarbonyl substituted flavanols has not been fully stud-
that are abundantly existed in the grape seed and berry fruits ied, but the annular acylations on the A rings of catechin and
[64-66]. They have been reported to be effective antibacterial procyanidin B2 have been reported to decrease their activity
agents against both sensitive and multi-drug resistant strains against S. aureus [73]. In general, the antibacterial activity of
[67, 68]. Proanthoxyanidins are divided into two types ac- polymeric procyanidins are only moderate compared with
cording to the linkage between the flavans: type A refers to the antibiotics, but their real merits for anti-bacteria may lie
those where constituent flavanyl moieties are linked via only in that they suppress -lactamase to decrease the stability of
one bond, while type B posses an second ether linkage to C bacterial cell membrane and consequently low the MIC of
(2) of the terminal flavanyl unit (Fig. 5). Karioti et al. iso- antibiotics for drug-resistant bacteria such as MRSA [74].

OH OH R1
O
OH OH OH
OH
O
HO O 2 HO O 2 HO O
R1 R1 OH
OH
4 O 4 O R2
OH OH HO
7 7 R3 OH
OH OH OH
8 8 A:gallate
O OH
(+)-Catechin(C): R1=R2=H, R3=OH
O OH
(+)-Catechin-3-gallate(CG): R1=R2=H,R3=A
HO HO OH
(-)-Epicatechin(EC): R1=R3=H, R2=OH
* (-)-Epicatechin-3-gallate(ECG): R1=R3=H, R2=A
OH OH
HO HO (-)-Epigallocatechin(EGC): R1=R2=OH, R3=H
O OH (-)-Epigallocatechin-3-gallate(EGCG): R1=OH, R3=H,R2=A
EPA: R1=OH,* = (+)-Gallocatechin(GC): R1=R3=OH, R2=H
HO
ProcyanidinA2: * = (+)-Gallocatechin-3-gallate(GCG): R1=OH, R2=H,R3=A
ProcyanidinA1:* = OH OH
HO
OR2 OH
Cinnamtannin B-1 Theaflavins:
OH OH OH T F1: R1=R2=H
HO O
OH
OH T F2A: R1=H,R2=galloyl
OH OH
2 T F2B: R1=galloyl,R2=H
HO O 8 TF3: R1=R2=galloyl
R1 HO O HO O
4 HO R5 OH
7 2
O7 A 3
OH OH
4 OR1
O R3
OH 8 R2 R4 OH O
OH R1 OH
O O HO
OH
HO
ProcyanidinB1: R1=(b-8)-(+)-catechin, R2=R3=R5=H,R4=OH 8
7-O
OH OH ProcyanidinB2: R1=(b-8)-(-)-epicatechin, R2=R3=R5=H,R4=OH
HO
Annular acyl
ProcyanidinB3: R1=H,R2=(a-8)-(+)-catechin,R3 =OH,R4=R5=H
ProcyanidinB4: R1=H,R2=(a-8)-(-)-epicatechin,R3 =OH,R4=R5=H
Flavanol trimer:ixoratannin A-2 Epicgallocatechin-(4b-8)-catechin: R1=(b-8)-(-)-epicatechin, R2=R3=H,R4=R5=OH
Epicatechin-(4b-8)-gallocatechin: R1=(b-8)-(+)-gallocatechin, R2=R3=H,R4=R5=OH

Fig. (5). Structures of antibacterial flavanols.

Antibacterial Activities of Flavonoids
2.5. Chalcone
Chalcones, extensively existed in edible plants, are usu-
ally regarded as the open-chain flavonoids, in which the two
aromatic rings are linked by a three-carbon
,-unsaturated
carbonyl system [75]. They have exhibited various biological
activities and been demonstrated to be the compounds re-
sponsible for the antibacterial effects of some medicinal
plants [76-78]. Nowakowska has summed the anti-infective
activity of synthetic and naturally occurring chalcones, and
discussed the structure requirements of effective antibacterial
chalcones. It has been suggested that hydroxyl groups espe-
cially the one at 4' position are likely to induce and enhance
the activity, while the methoxyl group tends to reduce or
eliminate the activity, and that the lipophilicity of ring A
substituents plays important role in modulating the activity
[79]. In the more recent review by Sahu, the necessary of
hydroxyl group at 4 position and the importance of lipophilic
substituents such as prenyl and hexyl groups in the molecular
structure were inferred, and the presentation of electron-
attracting groups was also regarded as the positive factor for
antibacterial activity [80]. Based on the above two reviews,
the newest literatures were discussed here to make an update.
At first, it has been demonstrated that 2',4'-
dihydroxychalcone isolated from Muntingia calabura L.
leaves showed antibacterial activity against methicillin-
sensitive S. aureus (MSSA) and MRSA with MIC values of
50 and 100 mg mL-1, respectively [77]. The result may tes-
tify the important role of hydroxyl group at 4' position.
However, in another study by Tran and coworkers, a total of
30 chalcone analogues was synthesized and screened for
their in vitro antibacterial activity against MSSA and MRSA,
and only 4 chalcones showed activity [81]. Analyzing the
structure-activity relationships of the chalcons, it is interest-
ing to see that chalcones with hydroxyl group at 2 or 4 posi-
tions at ring B show antibacterial activity, while the 2'-
hydroxyl group at ring A actually is not necessary for the
5 OH
4
B B
5'
HO 3 HO
b b
A 2
a a
3'
OH O OH
2',4'-dihydroxychalcone
HO OH
Ar Ar
O O
Ar: 2-Furyl
Ar O O Ar
O O
Ar: 4-Chlorophenyl
Active bischalcone derivatives
Fig. (6). Structures of antibacterial chalcones.
Current Medicinal Chemistry, 2015, Vol. 22, No. 1 137
activity. Nevertheless, the methoxylation still shows to
eliminate the activity. Besides, with 4' and 4 dihydroxyl
groups and a substituent of cinnamoyl ester derivate,
gemichalcone A has been found to be inactive for the activ-
ity agaisnt both A. baumannii and E. coli[29]. In addition to
the alterations on the substitution pattern of the aromatic
rings, some heterocyclic chalcone analogues were synthe-
sized to evaluate their antibacterial activity against MSSA
and MRSA. According to the results, it is indicated that re-
placement of aromatic ring B by heterocyclic ring containing
nitrogen, oxygen, or sulfur atoms dose not significantly en-
hance the antibacterial activity [82]. More over, some
bischalcone derivatives have also been synthesized and in-
vestigated on their activity against E. coli, P. aeruginosa,
and C. albicans. The structure-activity relationship revealed
that the compounds having free hydroxyls were more active
than those of the compounds having methoxy groups, and
the presence of electron withdrawing groups like chloro in-
creased the activity [83]. For dihydrochalcones, it has been
suggested before that reduction of the double bond exposed
negative effect on the activity [84]. The recent studies have
showed that both the C-benzylated dihydrochalcone and the
dihydrochalcone dimer were found to be inactive for antibac-
terial activity against M. tuberculosis [23]. The structures of
the referred antibacterial chalcones are shown in Fig. (6).
2.6. Aurone
Aurones are naturally existed in plants and responsible
for the bright yellow color of some important ornamental
flowers [85]. Besides the roles as pigments, aurones exhibit
various health beneficial characters such as antiviral, anti-
fungal, anticancer and antidiabetic activities [86, 87].
Aurones have two types of configurations (Z/E) due to the
double bond geometry (Fig. 7). Ferreira et al. isolated a hep-
tasubstituted (E)-aurone glucoside (HAG) from Gomphrena
agrestis and found it was active against 5 strains among 22
OCH3
HO B
R1
2
A b
A
R a
R2
O O
OH O
R= O
HO R1=OH
OCH3
R2=
Gemichalcone A OH
C-benzylated dihydrochalcone
O OH
B
N R1=OCH3
R2=
R
O HO OH
O
H3CO
S
Heterocyclic chalcone analogues Dihydrochalcone dimer
138 Current Medicinal Chemistry, 2015, Vol. 22, No. 1 Xie et al.

R1 R2

R2 HO O H
R3
O
R3 R1 R4
H O
OH
O R5
Z E
1. R1= R2= R3= OCH3 HAG: R2= R5=OH, R2= R3=OCH3, R4=gulcopranosyl
2. R1= R3= H, R2= N(CH3)2 Dunaurone: R1= R2=H, R3= R5=OH, R4=rutinosyl
3. R1= H, R2=R3= OH Dunaurone alycone: R1= R2=H, R3= R5=R4=OH

Fig. (7). Structures of antibacterial aurones.

tested bacteria [88]. Erazo et al., isolated dunaurone and its
aglycone (E-aurones) from Dunalia spinosa Dammer and
found both of them were weak antibactrail agents [89]. In
addition, Venkateswarlu et al. prepared a series of Z and E
aurones and evaluated their antimicrobial activity using agar-
cup plate diffusion method [87]. As they found, Z-aurones
exhibited potent activity against gram-positive organisms,
whereas the corresponding E-isomers exhibit no activity
even with high dosage, indicating the importance of Z-
configuration for the antibacterial activity of aurones. More
over, the aurone with dimethylamine group at the 4 position
showed weaker activity than those with hydroxyl or
methoxyl groups.
2.7. Isoflavanoids
Isoflavonoids are structurally characterized by a 3-
phenylchromen-4-one backbone where the phenolic B ring is
attached to the 3-C of ring C (Fig. 8). According to the struc-
tural pattern of ring C, they are classified into several sub-
classes such as isoflavone, isoflavanone, isoflavan, and
pterocarpan. Isoflavonoids are abundantly existed in pea
family plants and enter into human diet through soymilk and
soybean derivative foods. They are biological active com-
pounds such as phytoestrogens, inflammation inhibitors, and
antibacterial agents [90-93]. The structure prerequisites of
isoflavones as antibacterial agents have been discussed in a
mini review by Mukne et al., it has been concluded that the
presentation of prenyl groups, hydroxyl groups, and aryl
subsituions is very important for the activity, while methoxy-
lation of the hydroxyl group and cyclization between hy-
droxyl and prenyl group tend to decrease the activity [94].
For example, lupalbigenin substituted by 6,3-diprenyls has
been demonstrated to be the most potent antibacterial agents
against S. aureus (MIC, 4 g mL-1) and MRSA SK1 (MIC, 4
g mL-1) . Among the 17 isoflavone derivatives isolated
from Derris scandens Benth [95]. In addition, 6,8-
diprenylation of genestein gives it strong activity against the
oral gram-positive bacterium S. mutans with a MIC value of
4 g mL-1, while gancaonin G derived from genestein with
6-prenylation and methylation of 7-OH only shows moderate
activity against S. mutans (MIC,128 g mL-1) [96]. More
over, cyclization between 4-OCH3 and 5 prenyl group dra-
matically decreases the activity of erylatissin A against S.
aureus and B. subtilis, of which the minimum inhibitory
dosage enhances from 0.1 g to 1 g in a test using TLC
bioautographic technique [97].
Compared with isoflavones, isoflavanones have shown
moderate antibacterial activity, for example, platy-
isoavanone A(S) isolated from Platycelphium voense has
exhibited activity against M. tuberculosis with MIC of 23.7
mmol L-1 in the microplate alamar blue assay [98]. Besides,
glabridin, an isoflavan, has showed potent activity against

R3 HO O HO O HO O
R1O O OH OH
OH OH
A C OH
R4
R2 OH O
B OH O OH O
OCH3 OCH3
OH O OCH3
OH

Genistein derivates:
Lupalbigenin:R1=R3=H, R2=R4=prenyl
Gancaonin G:R1=CH3, R2=prenyl, R3=R4=H Erylatissin A Erythrabissin-1 Erystagallin A
6,8-diprenylgenistein:R1=R4=H, R2=R3=prenyl

HO O
HO O HO O
OCH3
OH HO O
O
OH O OH
O OH O
OCH3
O
OH

Erylatissin B Platyisofavanone A Eryvarins J Erythrabyssin II

Fig. (8). Antibacterial isoflavonoids and pterocarpans.

Antibacterial Activities of Flavonoids
Gram-positive strains such as S. aureus and S. epidermidis
(MIC: 3.9~7.5 g mL-1), but weak activity against gram-
negative strains such as S. typhi and E. coli (MIC: 125~250
g mL-1) [99].
Pterocarpan is regarded as derivates of isoflavonoids
formed by coupling the B ring to the 4-one position of
isoflavanons. The prenylated pterocarpans have shown anti-
bacterial activity, and it is noteworthy that the double preny-
lations are more favorable for the activity. For example,
erythrabissin-I with single prenyl group shows potent activ-
ity against MRSA strains (MIC, 6.25~12.5 g mL-1), and
the double prenylated erystagallin A shows greater activity
than erythrabissin-I (MIC, 0.78~3.13g mL-1) [100]. Be-
sides, erythrabyssin II with two prenyl groups at separate
rings has shown effective activity against MRSA strains
(MIC, 0.78~1.56g mL-1), while eryvarin J with two prenyl
groups both at the A ring has been demonstrated to be inac-
tive to MRSA [100, 101].
2.8. Bioflavonoids
Bioflavonoid, as the name suggests, refers to the flavon-
oid consisting of two monomeric subunits. The linkage sites
of the flavonoid subunits are either on the backbone or on the
subsituents of flavonoid units (Fig. 9). Bioflavonoids are
widely distributed in plant derived foods and beverages and
have been regarded as health beneficial ingredients [102,
103]. Mbukwa et al., investigated the antibacterial activity of
5,7,3',5'',7'',4'''-hexahydroxy (4'-O-3''')-biflavone using the
bioautographic agar overlay assay [104]. It was demon-
strated that the bioflavone was less sensitive to gram-positive
and gram-negative bacterial strains compared with its
subunit luteolin. In addition, being a lavandulyl substituted
flavanone, remangiflavanones A showed potent activity
against S. aureus S. epidermidis, and Enterococcus sp., how-
ever, remangiflavanones C consisting of two remangi-
flavanones A subunits linked together by a methylene group
was totally inactive against the above bacteria [105]. These
OH
HO O O
OH
HO O
OH O OH
OH O
Amentoflavone
O O
OH
O OH
Remangiflavanones C
Fig. (9). Structures of antibacterial bioflavonoids.
Current Medicinal Chemistry, 2015, Vol. 22, No. 1 139
results seem to suggest that formation of dimmers between
flavonoids reduces the antibacterial activity.
3. STRUCTURE-ACTIVITY RELATIONSHIP
The structure-activity relationships for flavonoids as an-
tibacterial agents have been discussed in several previous
reviews [16, 22, 79, 80, 106]. Based on them, a brief sum-
mary on the structural requirements of flavonoids as antibac-
terial agents was draw before the discussion: Flavone: O-acl
or O-alkylamino chain at C-7. Flavanone: 2',4' or 2',6'-
dihydroxylation of the B ring ; 5,7-dihydroxylation of the A
ring; 6 or 8 position with a long chain aliphatic group such as
lavandulyl or geranyl. Isoflavanone: 5-hydroxyl group plus
one, two or three additional hydroxyl groups at the 7, 2', 4'
positions. Chalcones: 2' or 4' hydroxylation; lipopholicity of
ring A. Flavan-3-ol class: substitution with C8 and C10
chains. Here in, an update on the structure-activity relation-
ships was made.
The recent studies (2011~2014) have exhibited that 5,7-
dihydroxyl substitution pattern is an indictor for antibacterial
activity for flavones, and additional hydroxyl group at 4'
position greatly increases the activity, while the methylation
of these hydroxyl groups reduces the activity with different
degrees; besides, addition of 3-hydroxyl group seems to en-
hance the activity, indicating flavonols may be better anti-
bacterial agents than flavones [69, 107, 108]. In addition to
the simple hydroxyl or methoxyl groups, some hydrocar-
bonly and nitrogen or oxygen-containing substituents may
significantly affect the antibacterial activity of flavones. As
shown in Table 1, almost all the hydrophobic substituents
increase the activity, and the substitution by straight aliphatic
chain and 6 member heterocyclic moieties such as mor-
pholinyl and piperidinyl groups significantly enhance the
activity. Interestingly, the proper length of the aliphatic chain
for maximum activity of hesperetin derivates has been found
to be twelve carbon atoms [47]. Generally, the saturation of
C3-C4 bond has been known to influence the affinities of
OH
HO O
OH
HO O
O
OH O
5,7,3',5'',7'',4'''-hexahydroxy (4'-O-3''')-biflavone
OH
HO
OH O
140 Current Medicinal Chemistry, 2015, Vol. 22, No. 1 Xie et al.

Table 1. Effects of hydrocarbonyl substitution on the antibacterial activity of flavones.

Flavones Flavones Position Substitution Effect Ref.

7,3,4-Trihydroxylflavone 8H = [28, 128]

5,7,2,4-Pentahydroxylflavone 3-C,8-C
[27]

Oroxylin A 7OH
[30]

Oroxylin A 7OH
[30]

Chrysin 7OH-(CH2)3-6
[31, 32]

Chrysin 7OH-(CH2)3-6
[31, 32]

Chrysin 7OH-(CH2)3

[32]

Chrysin 7OH-(CH2)3

[32]

Chrysin 7OH-(CH2)5

[31]

Chrysin 7OH-(CH2)5

[31]

Apigenin 8-C CH2-N-(CH 2)n-CH3
[34]

Apigenin 8-C

[34]

Apigenin 8-C
[34]

Apigenin 8-C

[34]

flavonoids for proteins and their biological activities [109-
111]. For antibacterial activity, it has been revealed that
flavanone showed higher activity than the corresponding
flavone. Notably, lots of the active antibacterial flavanones
are prenylated. As shown in Table 2A, prenyl flavanones
mostly show activity against gram-positive bacteria. Di-
prenylated flavanones exhibit higher activity than the ones
with single prenyl group. In addition, compared the activity
of geranyl and lavandulyl flavanones against S. aureus and
MRSA (Table 2B), it is found that both geranyl group and
lavandulyl group ensure the activity of flavanones, and either
hydroxylation or oxidation of the two groups will reduce or
even eliminate the activity. More over, the substitutive
prenyl group is able to form a heterocyclic ring with the ad-
jacent hydroxyl group on the ring of flavonoids, which in-
crease the antibacterial activity in some cases. For instance,
as shown in Table 3, when the 6 prenyl group joins with the
7 hydroxyl group, compound 2 turns into compound 19, with
about two times increasing activity against MRSA and seven
times that against S. aurue.
4. MECHANISM
There are plenty of literatures concerning the antibacte-
rial mechanism of flavonoids. Cushnie and Lamb [22] have
suggested in their review that the direct antibacterial activity
of flavonoids was mainly attributed to three mechanisms: (1)
Inhibition of nucleic acid synthesis: for example, it has been
observed that the global synthesis of DNA and RNA in V.
harveyi cells was dramatically inhibited after addition of
genistein for 15mins [112]. (2) Inhibition of cytoplasmic
membrane function: for example, galangin has exhibited its
antibacterial activity by causing marked increase in potas-
sium loss from S. aureus cells, indicating a direct damage to
the cytoplasmic membrane of S. aureus cell wall [113]. (3)
Inhibition of energy metabolism: for example, Eumkeb and
Chukrathok have recently suggested that apigenin and
Antibacterial Activities of Flavonoids Current Medicinal Chemistry, 2015, Vol. 22, No. 1 141

Table 2. Active antibacterial prenyl flavanones (A) and active geranyl and lavandulyl flavanones against S. aureus and MRSA (B).

Table 2A.

Activities (MIC, ug/mL)

Position Other Subsitutions Ref.
Gram Positive Gram Negative

8, 5' # 5,7,2',4'-OH(S) S. aureus/1.56; MRSA/1.56 - [39]

8, 5'# 5,7, 4'-OH, 2'-OCH3 (S) S. aureus/3.13; MRSA/3.13 - [39]

8, 5'# 5,7,2',4'-OH S. aureus/3.13; MRSA/3.13 - [39]

8 5,7,2',-OH(S) S. aureus/5.0 ; B. Subtilis/5.0 - [53]

8#, 5' 5,7,4'-OH M. Luteus/0.5* E. coil/0.5* [129]

6#, 5' 5,7,4'-OH M. Luteus/0.5* E. coil/0.5* [129]

8 5,7,2',4'-OH(S) S. aureus/5.0 ; B. Subtilis/2.5 - [53]

8 5,7,2',4'-OH, 5'-OCH3 (S) S. aureus/10 ; B. Subtilis/10 - [53]

6 5,7,2',4'-OH, 5'-OCH3 (S) S. aureus/10 ; B. Subtilis/10 - [53]

8 5,7,3' -OH, 8-OCH3 (S) S. aureus/100 - [41]

6 5,7,3'-OH, 6-OCH3 (S) S. aureus/100 - [41]

5' 7,3' -OH, 4'-OCH3 (S) S. aureus/0.5*; B. Subtilis/0.1* E.coli/0.01*, [97]

3' 5,7,4'-OH, 5'-OCH3 S. aureus/16; MRSA/16 - [130]

3' 5,7,4'-OH, 6'-OCH3 S. aureus/16; MRSA/16 - [130]

* Minimum growth inhibition amount on TLC (g); #:

Table 2B.

No Geranyl Lavandulyl Other Subsitutions MIC(ug/mL) Ref.

1 - 5,7,2',4'-OH (S) inactive [53]

8,

2 - 5,7,2',4'-OH(S) S. aureus/5.0; [53]

8,

3 - 5,7,2',4'-OH(S) S. aureus/2.5; [53]

8,

4 - 5,7,2'-OH(S) inactive [53]

8,

5 - 5,7,2'-OH(S) S. aureus/5.0 [53]

8,

6 - 5-OCH3;7,2',4'-OH(S) S. aureus/2.5 [53]

8,

7 - 5-OCH3;7,2',4'-OH(S) S. aureus/7.1 [131]

8,
142 Current Medicinal Chemistry, 2015, Vol. 22, No. 1 Xie et al.

(Table 2B) contd….

No Geranyl Lavandulyl Other Subsitutions MIC(ug/mL) Ref.

8 - 5-OCH3;7,2',4'-OH(S) S. aureus/219 [131]

8,

9 - 5-OCH3;7,2',4'-OH(S) inactive [53]

8,

10 - 3'-OCH3;5,7 ,4'-OH(S) S. aureus/16 [52]

6,

11 - 3'-OCH3;5,7 ,4'-OH(S) inactive [52]

6,

12 - 3'-OCH3;5,7 ,4'-OH(S) S. aureus/8 [52]

6,

13 - 3'-OCH3;5,7,4',5'-OH(S) S. aureus/2 [52]

6,

S. aureus/4
14 - 3'-OCH3;5,7,4',5'-OH(S) [46]
6, MRSA/4~8

15 - 3',5'-OCH3;5,7,4'-OH(S) S. aureus/4 [52]

6,

S. aureus/2
16 - 3',5'-OCH3;5,7,4'-OH(S) [46]
6, MRSA/4~8

S. aureus/2
17 - 5,7, 3',5'4'-OH(S) [46]
6, MRSA/2~4

S. aureus/8
18 - 3'-OCH3;5,7 ,4'-OH(S) [46]
6, MRSA/8~16

S. aureus/>64
19 - 3'-OCH3;5,7 ,4'-OH [46]
MRSA/
64
6,

S. aureus/16
20 - 3'-OCH3;5,7 ,4'-OH(S) [46]
MRSA/16~64
6,

S. aureus/64
21 - 3'-OCH3;5,7 ,4'-OH(S) [46]
6, MRSA/8~64

22 - 3'-OCH3;5,7 ,4'-OH(S) inactive [46]

6,

23 - 3'-OCH3;5,7 ,4'-OH inactive [46]

6,

24 - 2',4',6' -OH MRSA/12.5 [43]

6,

25 - 2',4',6' -OH MRSA/12.5 [43]

8,

26 - 2',4',6' -OH MRSA/3.13~12.5 [43]

6,
Antibacterial Activities of Flavonoids
No Geranyl Lavandulyl
27
8,
28
3'
29
6,
30
6,
31
2'
32
3',
1: Kushenol P; 2: Kushenol Q; 3: Kushenol R; 4: Kushenol T; 5: 8-Lavandulyl- 5,7,2'-trihydroxylflavanone; 6: 8-Lavandulyl-5-methoxyl-7,2',4'-trihydroxyflavanone; 7: Kurarinone;
8: Kurarinol; 9: 5-Methoxykushenol P ; 10: tomentodiplacone; 11: tomentodiplacone B; 12: 3'-O-methyldiplacone; 13/14: 3'-O-methyl-5'-hydroxydiplacone; 15/16: 3'O-methyl-5'-O-
methydiplacone; 17: 6-Greanyl-5,7, 3',5',4'-pentaflavanone; 18: tomentodiplacone B ; 19~22: Tomentodiplacone C, D, E, F; 23: Tomentodiplacone I; 24: Exiguaflavanone C; 25:
Exiguaflavanone G; 26 Sophoraflavanone D; 27:Sophoraflavanone E; 28: Myrsininone B; 29: Nymphaenol A; 30: Prokinawan; 31: Isonymphaeol B; 32: propolin B.
naringenin altered the outer and cytoplasmic membrane of E.
cloacae cell, consequently disturbed the exchange of nutri-
ents and metabolites and finally inhibited the energy supply
for the bacterium [114]. In another review, the inhibition of
cell membrane synthesis and the aggregatory effect on whole
bacterial cells also have been assumed to be possible mecha-
nism of antibacterial activity of flavonoids [16].
Here in, based on the former reviews, the latest ad-
vancements on the antibacterial mechanism of flavonoids are
covered and discussed. Recently, the inhibitory mechanism
of a series of flavone-based analogues on DNA gyrase of
E.coli has been studied, and the inhibitors were demonstrated
to inhibit the activity of gyrase through intercalating into
DNA, while another natural product simocyclinone D8 acted
as the competitive binders of DNA to handle the function of
gyrase [115]. Concerning the activity of EGCG against E.
coli, it has been found that EGCG interacts with the porin
protein of the outer membrane of E. coli, thereby inhibiting
the major function of the porin, namely the transport of small
hydrophilic molecules such as glucose, finally leading to
inhibition against the growth of E. coli [116]. Besides, it has
been revealed that the proanthocyanidin offers protection
against both sensitive as well as multi-drug resistant strains
of E. coli by inhibiting the adherence of multi-drug resistant
strains on uroepithelial cells [67]. Similar mechanism has
also been proposed for tea components inhibiting the at-
tachment and subsequent biofilm formation of S. mutans on
tooth surfaces. It is suggested that flavonoids coat the sur-
faces of cells, probably altering cell surface properties and
consequently disturbing the interactions between bacterial
cells and the surface of the substratum [117]. In addition to
the direct antibacterial activity, the synergistic and antibiot-
ics resistance modulating activity of flavonoids has gotten
better understanding. The investigation on synergistic effect
of apigenin and ceftazidime combination against ceftaz-
idime-resistant E. cloacae strains has revealed three possible
mechanisms of action by apigenin including the peptidogly-
can synthesis inhibition, the inhibition the activity of certain
Current Medicinal Chemistry, 2015, Vol. 22, No. 1 143
(Table 2B) contds….
Other Subsitutions MIC(ug/mL) Ref.
- 2',4',6' -OH MRSA/6.25~12.5 [43]
- 5,7 ,4'-OH(S) MRSA/1.9 [44]
- 5,7,3',4'-OH(S) S. aureus/4 [132]
- 5,7,3',4'-OH(S) inactive [132]
- 5,7,3',4'-OH(S) S. aureus/16 [132]
- 5,7,3',4'-OH(S) inactive [132]
-lactamase enzymes and the alteration of the outer and cy-
toplasmic membrane permeabilization [114]. In addition, the
mechanism of inhibition on the efflux pump of antibiotic
resistant bacteria has been further proposed on the synergis-
tic effects of flavonoids isolated from A. katsumadai in com-
bination with rifampicin against M. smegmatis [118]. Be-
sides, the synergy of a ciprofloxacin–pomegranate pericarp
extract combination was exhibited against extended-
spectrum -lactamase and metallo--lactamase producing
Gram-negative bacilli, which was attributed to the bacterial
efflux pump inhibitor activity of the polyphenolic constitu-
ents of the pomegranate pericarp extract [119]. Some times,
multi mechanism was observed for antibacterial activity, a
flavonoid rich extract of Glycyrrhiza glabra has exerted anti-
H. pylori activity possibly by inhibiting protein synthesis,
DNA gyrase and dihydrofolate reductase [120].
Besides of the antibacterial activity, flavonoids may
show activity of reducing the harm of bacteria to the host
organism. In the U937cells and monocytes infected by S.
typhimurium, flavonoids such as resveratrol and quercetin
reduced the NO production, inhibited the cell viability and
proliferation in the infected cells, and consequently protected
the host cells from the toxic effects of bacterial infection and
decreased programmed cell death [121]. Isoliquiritigenin and
liquiritigenin have also shown their oral infection therapeutic
potential by targeting host cell receptors activated by three
periodontopathogens [122]. In addition, naringenin and taxi-
folin have been found to attenuate the production of quorum
sensing (QS)-controlled virulence factors in P. aeruginosa
[123]. More over, some prenylated isoflavones from roots of
Flemingia philippinensis have proven to be active com-
pounds for inhibition against bacterial neuraminidase which
is one of the key enzymes involved in pathogenesis of
inflammation during infection. The structure–activity analy-
sis showed a 4-hydroxyl group within the B-ring was essen-
tial for neuraminidase inhibitory activity, and the di-prenyl
substituents also seemed to be important for the activity
[124].
144 Current Medicinal Chemistry, 2015, Vol. 22, No. 1 Xie et al.

Table 3. Active antibacterial prenylated flavanols.

No Prenyl Subsitutions Other Subsitutions Antibactrial (MIC, ug/mL) Ref.

C. albicans/25 ; S. Cerevisiae/12.5 ; E. Coli/20 ; S. Typhimu-

1 5,7,2',4'-OH [27]
6,5' rim/25 ; S. epidermis/10 ; S. Aureus/15

2 *5,7,2',4'-OH(S) MRSA/62.5; S. aureus/125 [55]

6,

3 *5,7,2',4'-OH(S) MRSA/62.5; S. aureus/62.5 [55]

8,

4 *5,2',4'-OH(S) B. cereus/<50; B. subtilis/<50 [133]

7-O

5 *5,7,4'-OH(S) B. cereus/200; B. subtilis/200 [133]

6,

6 *5,7,4'-OH, 3'-OCH3 (S) B. cereus/<25; B. subtilis/50 [133]

6,

7 8, *5,7,2',6'-OH
4'-OCH3 S. epidermis/20 ; S. Aureus/20 [27]

6,

6, S.aureus/24.6 ; B. subtilis/12.3 ; S.typhimurium/12.3 ;

8 *5,7,2',4'-OH(S) [131]
P. vulgaris/6.14

8,

9 *5,7,2',4'-OH(S) S. aureus/10; B. subtilis/10 [53]

8,

S.aureus/27.5 ; B. subtilis/13.8 ; S.typhimurium/27.5 ;

10 *7,2',4'-OH, 5-OCH3(S) [53]
P. vulgaris/27.5
8,

S.aureus/27.5 ; B. subtilis/13.8 ; S.typhimurium/27.5 ;

11 *7,2',4'-OH, 5-OCH3(R) [53]
P. vulgaris/27.5
8,

S.aureus/236 ; B. subtilis/118 ; S.typhimurium/236 ;

12 5,7,4'-OH [53]
P. vulgaris/118
8,

B. cereus, L. monocytogenes, S. aureus & S. epidermidis/2 ;

13 *5,7,4'-OH
3'-OCH3 (S) [46, 52]
6, B. subtilis & E. faecalis/4 ; (S. aureus/4, MRSA/4~8)

14 5,7,3',4'--OH S. aureus/32, B. subtilis/32, P. Aeruginosa/16 [132]

6,

15 5,7,3',4'--OH S. aureus/64, B. subtilis/64, P. Aeruginosa/64 [132]

2',

16 5,7,3',4'--OH S. aureus/64, B. subtilis/64, P. Aeruginosa/64 [132]

6,

17 4'-OCH3; 5,2',4'-OH S. aureus/2.01 ;S. sciuri/2.01 ; S. xylosus/2.01 [54]

6,7,
Antibacterial Activities of Flavonoids
No Prenyl Subsitutions Other Subsitutions
18 *4'-OCH3; 5,2',4'-OH(S)
6,7,
19 *5,2',4'--OH(S)
6,7,
20 *5, 4'-OH(S)
7,8,
21 *5, 3',4'-OH(S)
7,8,
* : dihydroflavnol; S/R: configurations (1) Papyriflavonol A (2) 6-prenyl-5,7,2',4'-pentahydroxyl –dihydroflavanol (3)8-prenyl-5,7,2',4'-pentahydroxyldihydroflavanol(4) 5,3,4-
Trihydroxy-7- (,-dimethylallyloxy)dihydroflavonol (5) 5,7,4-Trihydroxy-6-(
,
-dimethylallyl)dihydroflavonol (6) 5,7,4-Trihydroxy-3-O-methyl-6- (
,
-dimethylallyl)dihydrofla-
vonol (7) Kenusanone C (8) Kushenol M (9) Kushenol X (10) Kushenol I(11) Kushenol N (12) 8-lavandulylkaempferol (13) 3-O-methyldiplacol (14) Solophenol D (15) Solophenol
B (16) Solophenol C (17) Lanneaflavonol (18) Dihydrolanneaflavonol (19) 6,7-(2'',2''-dimethylpyrano)- 5,2',4'-trihydroxyldihydroflavanol (20) Yokuvanol (21) 3'-Hydroxylyokuvanol
CONCLUDING REMARK
With this review the structure-activity relationships for
flavonoids as antibacterial agents were discussed. It is con-
cluded that hydroxyl groups on special sites are favorable for
the activity, such as 5,7-dihydroxyl substitution for flavone
and flavanone, and 2' or 4' hydroxylation for chalcones. The
hydroxyl group at 3 position on the C ring also increases the
activity of flavone. However, the methylation of the hy-
droxyl groups generally decreases the activity. The
lipopholicity of the ring A is of great importance for the ac-
tivity of chalcones. Hydrophobic substituents such as prenyl
groups, alkylamino chains, alkyl chains, and nitrogen or
oxygen containing heterocyclic moieties usually enhance the
activity for all the flavonoids. In addition, the antibacterial
mechanisms of flavonoids are summed as follows: inhibition
of nucleic acid synthesis, inhibition of cytoplasmic mem-
brane function, inhibition of energy metabolism, inhibition
of the attachment and biofilm formation, inhibition of the
porin on the cell menbrane, alteration of the membrane per-
meability, and attenuation of the pathogenicity. Although the
current knowledge on the antibacterial activity of flavonoids
is far from clear, the huge potentials of flavonoids for con-
trolling the prevalence of antibiotic resistance microorgan-
isms are basically confirmed. However, it is noted that most
of the antibacterial activity of flavonoids were tested in vitro,
only few studies have investigated the activity in vivo [125,
126]. Hence, further studies is ought to pay more attention to
the relationships between the bioavailability and antibacterial
activity of flavonoids. The possibility of resistance of bacte-
ria to flavonoids should also be evaluated in advance. Never-
theless, flavonoids have surely become an alternative choice
for tackling the so called “antibiotic resistance crisis” [127].
CONFLICT OF INTEREST
The authors confirm that this article content has no con-
flict of interest.
ACKNOWLEDGEMENTS
The authors thank for the financial support from National
Natural Science Foundation of China (21175155 & 21276282).
Current Medicinal Chemistry, 2015, Vol. 22, No. 1 145
(Table 3) contd….
Antibactrial (MIC, ug/mL) Ref.
S. aureus/2.00 ;S. sciuri/2.00 ; S. xylosus/2.00 [54]
MRSA/31.3; S. aureus/15.6 [55]
MRSA/31.3; S. aureus/31.3 [55]
MRSA/15.6; S. aureus/15.6 [55]
REFERENCES
[1] Davies, J. Inactivation of antibiotics and the dissemination of
resistance genes. Science (New York, N.Y.), 1994, 264(5157), 375-82.
[2] Alanis, A. J. Resistance to antibiotics: Are we in the post-antibiotic
era? Archives of Medical Research, 2005, 36(6), 697-705.
[3] Breithaupt, H. Tackling resistence: bacteria, humans, animals and
the environment. EMBO reports, 2014, 15(2), 127-130.
[4] Marchaim, D.; Zaidenstein, R.; Lazarovitch, T.; Karpuch, Y.; Ziv,
T.; Weinberger, M. Epidemiology of bacteremia episodes in a
single center: increase in Gram-negative isolates, antibiotics
resistance, and patient age. European Journal of Clinical
Microbiology & Infectious Diseases, 2008, 27(11), 1045-1051.
[5] Gao, W.; Cheng, H.; Hu, F.; Li, J.; Wang, L.; Yang, G.; Xu, L.;
Zheng, X. The Evolution of Helicobacter pylori Antibiotics
Resistance Over 10 Years in Beijing, China. Helicobacter, 2010,
15(5), 460-466.
[6] Yang, S. C.; Chang, W. J.; Chang, Y. H.; Tsai, Y. S.; Yang, T. P.;
Juan, C. W.; Shiau, M. Y. Prevalence of antibiotics resistance and
OXA carbapenemases genes in multidrug-resistant Acinetobacter
baumannii isolates in central Taiwan. European Journal of Clinical
Microbiology & Infectious Diseases, 2010, 29(5), 601-604.
[7] Brown, D. G.; Lister, T.; May-Dracka, T. L. New natural products
as new leads for antibacterial drug discovery. Bioorg. Med. Chem.
Lett., 2014, 24(2), 413-418.
[8] Taylor, P. W. Alternative natural sources for a new generation of
antibacterial agents. Int. J. Antimicrob. Agents, 2013, 42(3), 195-
201.
[9] Newman, D. J.; Cragg, G. M. Natural Products As Sources of New
Drugs over the 30 Years from 1981 to 2010. J. Nat. Prod., 2012,
75(3), 311-335.
[10] Cowan, M. M. Plant products as antimicrobial agents. Clinical
Microbiology Reviews, 1999, 12(4), 564-+.
[11] Butler, M. S. Natural products to drugs: natural product-derived
compounds in clinical trials. Natural Product Reports, 2008, 25(3),
475-516.
[12] Hatano, T.; Kusuda, M.; Inada, K.; Ogawa, T. O.; Shiota, S.;
Tsuchiya, T.; Yoshida, T. Effects of tannins and related
polyphenols on methicillin-resistant Staphylococcus aureus.
Phytochemistry, 2005, 66(17), 2047-2055.
[13] Tangney, C. C.; Rasmussen, H. E. Polyphenols, Inflammation, and
Cardiovascular Disease. Current Atherosclerosis Reports, 2013,
15(5).
[14] Bhattacharya, S. Are we in the polyphenols era? Pharmacognosy
Res, 2011, 3(2), 147-147.
[15] Xiao, J.; Kai, G. A review of dietary polyphenol-plasma protein
interactions: characterization, influence on the bioactivity, and
structure-affinity relationship. Critical reviews in food science and
nutrition, 2012, 52(1), 85-101.
146 Current Medicinal Chemistry, 2015, Vol. 22, No. 1
[16] Cushnie, T. P. T.; Lamb, A. J. Recent advances in understanding
the antibacterial properties of flavonoids. Int. J. Antimicrob.
Agents, 2011, 38(2), 99-107.
[17] Roccaro, A. S.; Blanco, A. R.; Giuliano, F.; Rusciano, D.; Enea, V.
Epigallocatechin-gallate enhances the activity of tetracycline in
staphylococci by inhibiting its efflux from bacterial cells.
Antimicrobial Agents and Chemotherapy, 2004, 48(6), 1968-1973.
[18] Eumkeb, G.; Siriwong, S.; Phitaktim, S.; Rojtinnakorn, N.;
Sakdarat, S. Synergistic activity and mode of action of flavonoids
isolated from smaller galangal and amoxicillin combinations
against amoxicillin-resistant Escherichia coli. J. Appl. Microbiol.,
2012, 112(1), 55-64.
[19] Tenover, F. C. Mechanisms of antimicrobial resistance in bacteria.
American Journal of Infection Control, 2006, 34(5), S3-S10.
[20] Daglia, M. Polyphenols as antimicrobial agents. Current Opinion
in Biotechnology, 2012, 23(2), 174-181.
[21] Fast, W.; Sutton, L. D. Metallo-beta-lactamase: Inhibitors and
reporter substrates. Biochimica Et Biophysica Acta-Proteins and
Proteomics, 2013, 1834(8), 1648-1659.
[22] Cushnie, T. P. T.; Lamb, A. J. Antimicrobial activity of flavonoids.
Int. J. Antimicrob. Agents, 2005, 26(5), 343-356.
[23] Prawat, U.; Chairerk, O.; Phupornprasert, U.; Salae, A. W.;
Tuntiwachwuttikul, P. Two New C-benzylated Dihydrochalcone
Derivatives from the Leaves of Melodorum siamensis. Planta
Med., 2013, 79(1), 83-86.
[24] Rashid, F.; Mahmood, A.; Ifzal, R.; Malik, A. Flavonoids of Prunus
armeniaca and their Antibacterial Studies. Journal of the Chemical
Society of Pakistan, 2013, 35(3), 905-910.
[25] Wang, P. C.; Ran, X. H.; Luo, H. R.; Zheng, Y. M.; Liu, Y. Q.; Hu,
J. M.; Zhou, J. Nardokanshone A, a new type of sesquieterpenoid-
chalcone hybrid from Nardostachys chinensis. Tetrahedron Letters,
2013, 54(33), 4365-4368.
[26] Wenzel, U. Flavonoids as drugs at the small intestinal level.
Current Opinion in Pharmacology, 2013, 13(6), 864-868.
[27] Sohn, H. Y.; Son, K. H.; Kwon, C. S.; Kwon, G. S.; Kang, S. S.
Antimicrobial and cytotoxic activity of 18 prenylated flavonoids
isolated from medicinal plants: Morus alba L., Morus mongolica
Schneider, Broussnetia papyrifera (L.) Vent, Sophora flavescens
Ait and Echinosophora koreensis Nakai. Phytomedicine (Jena),
2004, 11(7-8), 666-672.
[28] Yin, S.; Fan, C.-Q.; Wang, Y.; Dong, L.; Yue, J.-M. Antibacterial
prenylflavone derivatives from Psoralea corylifolia, and their
structure–activity relationship study. Bioorg. Med. Chem., 2004,
12(16), 4387-4392.
[29] Panthong, K.; Tohdee, K.; Hutadilok-Towatana, N.;
Voravuthikunchai, S. P.; Chusri, S. Prenylated Flavone from Roots
of a Hybrid between Artocarpus heterophyllus and Artocarpus
integer and its Biological Activities. Journal of the Brazilian
Chemical Society, 2013, 24(10), 1656-+.
[30] Suresh Babu, K.; Hari Babu, T.; Srinivas, P. V.; Sastry, B. S.; Hara
Kishore, K.; Murty, U. S. N.; Madhusudana Rao, J. Synthesis and
in vitro study of novel 7-O-acyl derivatives of Oroxylin A as
antibacterial agents. Bioorg. Med. Chem. Lett., 2005, 15(17), 3953-
6.
[31] Suresh Babu, K.; Hari Babu, T.; Srinivas, P. V.; Hara Kishore, K.;
Murthy, U. S. N.; Rao, J. M. Synthesis and biological evaluation of
novel C (7) modified chrysin analogues as antibacterial agents.
Bioorg. Med. Chem. Lett., 2006, 16(1), 221-4.
[32] Li, H.-Q.; Shi, L.; Li, Q.-S.; Liu, P.-G.; Luo, Y.; Zhao, J.; Zhu, H.-
L. Synthesis of C(7) modified chrysin derivatives designing to
inhibit
-ketoacyl-acyl carrier protein synthase III (FabH) as
antibiotics. Bioorg. Med. Chem., 2009, 17(17), 6264-6269.
[33] Lv, P. C.; Li, H. Q.; Xue, H. Y.; Shi, L.; Zhu, H. L. Synthesis and
biological evaluation of novel luteolin derivatives as antibacterial
agents. Eur. J. Med. Chem., 2009, 44(2), 908-914.
[34] Liu, R.; Zhao, B.; Wang, D. E.; Yao, T. Y.; Pang, L.; Tu, Q.;
Ahmed, S. M.; Liu, J. J.; Wang, J. Y. Nitrogen-Containing
Apigenin Analogs: Preparation and Biological Activity. Molecules,
2012, 17(12), 14748-14764.
[35] Zhao, X. B.; Mei, W. L.; Gong, M. F.; Zuo, W. J.; Bai, H. J.; Dai,
H. F. Antibacterial Activity of the Flavonoids from Dalbergia
odorifera on Ralstonia solanacearum. Molecules, 2011, 16(12),
9775-9782.
Xie et al.
[36] Yao, X. L.; Zhu, X. R.; Pan, S. Y.; Fang, Y. P.; Jiang, F. T.;
Phillips, G. O.; Xu, X. Y. Antimicrobial activity of nobiletin and
tangeretin against Pseudomonas. Food Chem., 2012, 132(4), 1883-
1890.
[37] Prawat, U.; Phupornprasert, D.; Butsuri, A.; Salae, A.-W.; Boonsri,
S.; Tuntiwachwuttikul, P. Flavonoids from Friesodielsia discolor.
Phytochem. Lett., 2012, 5(4), 809-813.
[38] Celiz, G.; Daz, M.; Audisio, M. C. Antibacterial activity of
naringin derivatives against pathogenic strains. J. Appl. Microbiol.,
2011, 111(3), 731-738.
[39] Suksamrarn, A.; Chotipong, A.; Suavansri, T.; Boongird, S.;
Timsulksai, P.; Vimuttilpong, S.; Chuaynugul, A.
Antimycobacterial activity and cytotoxicity of flavonoids from the
flowers of Chromolaena odorata. Arch. Pharm. Res., 2004, 27(5),
507-511.
[40] Manner, S.; Skogman, M.; Goeres, D.; Vuorela, P.; Fallarero, A.
Systematic Exploration of Natural and Synthetic Flavonoids for the
Inhibition of Staphylococcus aureus Biofilms. International
Journal of Molecular Sciences, 2013, 14(10), 19434-19451.
[41] Wachter, G. A.; Hoffmann, J. J.; Furbacher, T.; Blake, M. E.;
Timmermann, B. N. Antibacterial and antifungal flavanones from
Eysenhardtia texana. Phytochemistry, 1999, 52(8), 1469-1471.
[42] Nanayakkara, N. P. D.; Burandt, C. L.; Jacob, M. R. Flavonoids
with activity against methicillin-resistant Staphylococcus aureus
from Dalea scandens var. paucifolia. Planta Med., 2002, 68(6),
519-522.
[43] Tsuchiya, H.; Sato, M.; Miyazaki, T.; Fujiwara, S.; Tanigaki, S.;
Ohyama, M.; Tanaka, T.; Iinuma, M. Comparative study on the
antibacterial activity of phytochemical flavanones against
methicillin-resistant Staphylococcus aureus. J. Ethnopharmacol.,
1996, 50(1), 27-34.
[44] Kang, L.; Zhou, J. X.; Shen, Z. W. Two novel antibacterial
flavonoids from Myrsine Africana L. Chin. J. Chem., 2007, 25(9),
1323-1325.
[45] Prasad, S. K.; Laloo, D.; Kumar, M.; Hemalatha, S. Antidiarrhoeal
Evaluation of Root Extract, Its Bioactive Fraction, and Lupinifolin
Isolated from Eriosema chinense. Planta Med., 2013, 79(17), 1620-
1627.
[46] Navratilova, A.; Schneiderova, K.; Vesela, D.; Hanakova, Z.;
Fontana, A.; Dall'Acqua, S.; Cvacka, J.; Innocenti, G.; Novotna, J.;
Urbanova, M.; Pelletier, J.; Cizek, A.; Zemlickova, H.; Smejkal, K.
Minor C-geranylated flavanones from Paulownia tomentosa fruits
with MRSA antibacterial activity. Phytochemistry, 2013, 89, 104-
113.
[47] Zhang, B. S.; Ye, X. L.; Chen, Z.; Jiang, X. F.; Yuan, L. J.; Yi, J.;
Li, X. G. Synthesis and antimicrobial activity of 7-
alkoxyhesperetin derivatives. Med. Chem. Res., 2011, 20(8), 1200-
1205.
[48] Stermitz, F. R.; Scriven, L. N.; Tegos, G.; Lewis, K. Two flavonols
from Artemisa annua which potentiate the activity of berberine and
norfloxacin against a resistant strain of Staphylococcus aureus.
Planta Med., 2002, 68(12), 1140-1141.
[49] Wong, K. C.; Ali, D. M. H.; Boey, P. L. Chemical constituents and
antibacterial activity of Melastoma malabathricum L. Nat. Prod.
Res., 2012, 26(7), 609-618.
[50] Cespedes, C. L.; Avila, J. G.; Martinez, A.; Serrato, B.; Calderon-
Mugica, J. C.; Salgado-Garciglia, R. Antifungal and antibacterial
activities of Mexican tarragon (Tagetes lucida). J. Agric. Food
Chem., 2006, 54(10), 3521-3527.
[51] Teffo, L. S.; Aderogba, M. A.; Eloff, J. N. Antibacterial and
antioxidant activities of four kaempferol methyl ethers isolated
from Dodonaea viscosa Jacq. var. angustifolia leaf extracts. S. Afr.
J. Bot., 2010, 76(1), 25-29.
[52] Smejkal, K.; Chudik, S.; Kloucek, P.; Marek, R.; Cvacka, J.;
Urbanova, M.; Julinek, O.; Kokoska, L.; Slapetova, T.; Holubova,
P.; Zima, A.; Dvorska, M. Antibacterial C-geranylflavonoids from
Paulownia tomentosa fruits. J. Nat. Prod., 2008, 71(4), 706-709.
[53] Kuroyanagi, M.; Arakawa, T.; Hirayama, Y.; Hayashi, T.
Antibacterial and antiandrogen flavonoids from Sophora
flavescens. J. Nat. Prod., 1999, 62(12), 1595-1599.
[54] Okoth, D. A.; Chenia, H. Y.; Koorbanally, N. A. Antibacterial and
antioxidant activities of flavonoids from Lannea alata (Engl.) Engl.
(Anacardiaceae). Phytochem. Lett., 2013, 6(3), 476-481.
Antibacterial Activities of Flavonoids
[55] Sasaki, H.; Kashiwada, Y.; Shibata, H.; Takaishi, Y. Prenylated
flavonoids from Desmodium caudatum and evaluation of their anti-
MRSA activity. Phytochemistry, 2012, 82, 136-142.
[56] Aron, P. M.; Kennedy, J. A. Flavan-3-ols: Nature, occurrence and
biological activity. Molecular Nutrition & Food Research, 2008,
52(1), 79-104.
[57] Cao, H.; Shi, Y.; Chen, X. Advances on the Interaction between
Tea Catechins and Plasma Proteins: Structure-Affinity
Relationship, Influence on Antioxidant Activity, and Molecular
Docking Aspects. Current Drug Metabolism, 2013, 14(4), 446-450.
[58] Orak, H. H.; Yagar, H.; Isbilir, S. S.; Demirci, A. S.; Gumus, T.
Antioxidant and antimicrobial activities of white, green and black
tea extracts. Acta Alimentaria, 2013, 42(3), 379-389.
[59] Oh, J.; Jo, H.; Cho, A. R.; Kim, S. J.; Han, J. Antioxidant and
antimicrobial activities of various leafy herbal teas. Food Control,
2013, 31(2), 403-409.
[60] Bansal, S.; Choudhary, S.; Sharma, M.; Kumar, S. S.; Lohan, S.;
Bhardwaj, V.; Syan, N.; Jyoti, S. Tea: A native source of
antimicrobial agents. Food Research International, 2013, 53(2),
568-584.
[61] Zhang, Q.; Fan, D.; Xiong, B.; Kong, L.; Zhu, X. Isolation of new
flavan-3-ol and lignan glucoside from Loropetalum chinense and
their antimicrobial activities. Fitoterapia, 2013, 90, 228-232.
[62] Diaz-Gomez, R.; Lopez-Solis, R.; Obreque-Slier, E.; Toledo-
Araya, H. Comparative antibacterial effect of gallic acid and
catechin against Helicobacter pylori. LWT-Food Sci. Technol.,
2013, 54(2), 331-335.
[63] Betts, J. W.; Kelly, S. M.; Haswell, S. J. Antibacterial effects of
theaflavin and synergy with epicatechin against clinical isolates of
Acinetobacter baumannii and Stenotrophomonas maltophilia. Int. J.
Antimicrob. Agents, 2011, 38(5), 421-425.
[64] Lacombe, A.; McGivney, C.; Tadepalli, S.; Sun, X.; Wu, V. C. H.
The effect of American cranberry (Vaccinium macrocarpon)
constituents on the growth inhibition, membrane integrity, and
injury of Escherichia coli O157:H7 and Listeria monocytogenes in
comparison to Lactobacillus rhamnosus. Food Microbiology, 2013,
34(2), 352-359.
[65] Silvan, J. M.; Mingo, E.; Hidalgo, M.; de Pascual-Teresa, S.;
Carrascosa, A. V.; Martinez-Rodriguez, A. J. Antibacterial activity
of a grape seed extract and its fractions against Campylobacter spp.
Food Control, 2013, 29(1), 25-31.
[66] Radovanovic, B. C.; Andelkovic, A. S. M.; Radovanovic, A. B.;
Andelkovic, M. Z. Antioxidant and Antimicrobial Activity of
Polyphenol Extracts from Wild Berry Fruits Grown in Southeast
Serbia. Tropical Journal of Pharmaceutical Research, 2013, 12(5),
813-819.
[67] Gupta, A.; Dwivedi, M.; Mahdi, A.; Nagana Gowda, G. A.;
Khetrapal, C.; Bhandari, M. Inhibition of adherence of multi-drug
resistant E. coli by proanthocyanidin. Urol Res, 2012, 40(2), 143-
150.
[68] Al-Habib, A.; Al-Saleh, E.; Safer, A. M.; Afzal, M. Bactericidal
effect of grape seed extract on methicillin-resistant Staphylococcus
aureus (MRSA). Journal of Toxicological Sciences, 2010, 35(3),
357-364.
[69] Karioti, A.; Sokovic, M.; Ciric, A.; Koukoulitsa, C.; Bilia, A. R.;
Skaltsa, H. Antimicrobial Properties of Quercus ilex L.
Proanthocyanidin Dimers and Simple Phenolics: Evaluation of
Their Synergistic Activity with Conventional Antimicrobials and
Prediction of Their Pharmacokinetic Profile. J. Agric. Food Chem.,
2011, 59(12), 6412-6422.
[70] Shan, B.; Cai, Y.-Z.; Brooks, J. D.; Corke, H. Antibacterial
Properties and Major Bioactive Components of Cinnamon Stick
(Cinnamomum burmannii): Activity against Foodborne
Pathogenic Bacteria. J. Agric. Food Chem., 2007, 55(14), 5484-
5490.
[71] Idowu, T. O.; Ogundaini, A. O.; Salau, A. O.; Obuotor, E. M.;
Bezabih, M.; Abegaz, B. M. Doubly linked, A-type
proanthocyanidin turner and other constituents of Ixora coccinea
leaves and their antioxidant and antibacterial properties.
Phytochemistry, 2010, 71(17-18), 2092-2098.
[72] Mayer, R.; Stecher, G.; Wuerzner, R.; Silva, R. C.; Sultana, T.;
Trojer, L.; Feuerstein, I.; Krieg, C.; Abel, G.; Popp, M.; Bobleter,
O.; Bonn, G. K. Proanthocyanidins: Target compounds as
Current Medicinal Chemistry, 2015, Vol. 22, No. 1 147
antibacterial agents. J. Agric. Food Chem., 2008, 56(16), 6959-
6966.
[73] Ming, D. S.; Lopez, A.; Hillhouse, B. J.; French, C. J.; Hudson, J.
B.; Towers, G. H. N. Bioactive constituents from Iryanthera
megistophylla. J. Nat. Prod., 2002, 65(10), 1412-1416.
[74] Kusuda, M.; Inada, K.; Ogawa, T. O.; Yoshida, T.; Shiota, S.;
Tsuchiya, T.; Hatano, T. Polyphenolic constituent structures of
Zanthoxylum piperitum fruit and the antibacterial effects of its
polymeric procyanidin on methicillin-resistant Staphylococcus
aureus. Biosci. Biotechnol. Biochem., 2006, 70(6), 1423-1431.
[75] Kozlowski, D.; Trouillas, P.; Calliste, C.; Marsal, P.; Lazzaroni, R.;
Duroux, J.-L. Density Functional Theory Study of the
Conformational, Electronic, and Antioxidant Properties of Natural
Chalcones. The Journal of Physical Chemistry A, 2007, 111(6),
1138-1145.
[76] Kuete, V.; Simo, I. K.; Ngameni, B.; Bigoga, J. D.; Watchueng, J.;
Kapguep, R. N.; Etoa, F. X.; Tchaleu, B. N.; Beng, V. P.
Antimicrobial activity of the methanolic extract, fractions and four
flavonoids from the twigs of Dorstenia angusticornis Engl.
(Moraceae). J. Ethnopharmacol., 2007, 112(2), 271-277.
[77] Sufian, A. S.; Ramasamy, K.; Ahmat, N.; Zakaria, Z. A.; Yusof, M.
I. M. Isolation and identification of antibacterial and cytotoxic
compounds from the leaves of Muntingia calabura L. J.
Ethnopharmacol., 2013, 146(1), 198-204.
[78] Zhu, Y. D.; Zhang, P.; Yu, H. P.; Li, H.; Wang, M. W.; Zhao, W.
M. Anti-Helicobacter pylori and thrombin inhibitory components
from Chinese Dragon's blood, Dracaena cochinchinensis. J. Nat.
Prod., 2007, 70(10), 1570-1577.
[79] Nowakowska, Z. A review of anti-infective and anti-inflammatory
chalcones. Eur. J. Med. Chem., 2007, 42(2), 125-137.
[80] Sahu, N. K.; Balbhadra, S. S.; Choudhary, J.; Kohli, D. V.
Exploring Pharmacological Significance of Chalcone Scaffold: A
Review. Curr. Med. Chem., 2012, 19(2), 209-225.
[81] Tran, T. D.; Do, T. H.; Tran, N. C.; Ngo, T. D.; Huynh, T. N. P.;
Tran, C. D.; Thai, K. M. Synthesis and anti Methicillin resistant
Staphylococcus aureus activity of substituted chalcones alone and
in combination with non-beta-lactam antibiotics. Bioorg. Med.
Chem. Lett., 2012, 22(14), 4555-4560.
[82] Tran, T. D.; Nguyen, T. T. N.; Do, T. H.; Huynh, T. N. P.; Tran, C.
D.; Thai, K. M. Synthesis and Antibacterial Activity of Some
Heterocyclic Chalcone Analogues Alone and in Combination with
Antibiotics. Molecules, 2012, 17(6), 6684-6696.
[83] Husain, A.; Ahmad, A.; Mkhalid, I. A. I.; Mishra, R.; Rashid, M.
Synthesis and antimicrobial activity of bischalcone derivatives.
Med. Chem. Res., 2013, 22(4), 1578-1586.
[84] Avila, H. P.; Smania, E. D. A.; Delle Monache, F.; Junior, A. S.
Structure-activity relationship of antibacterial chalcones. Bioorg.
Med. Chem., 2008, 16(22), 9790-9794.
[85] Nakayama, T. Enzymology of aurone biosynthesis. Journal of
Bioscience and Bioengineering, 2002, 94(6), 487-491.
[86] Bandgar, B. P.; Patil, S. A.; Korbad, B. L.; Biradar, S. C.; Nile, S.
N.; Khobragade, C. N. Synthesis and biological evaluation of a
novel series of 2,2-bisaminomethylated aurone analogues as anti-
inflammatory and antimicrobial agents. Eur. J. Med. Chem., 2010,
45(7), 3223-3227.
[87] Venkateswarlu, S.; Panchagnula, G. K.; Gottumukkala, A. L.;
Subbaraju, G. V. Synthesis, structural revision, and biological
activities of 4
-chloroaurone, a metabolite of marine brown alga
Spatoglossum variabile. Tetrahedron, 2007, 63(29), 6909-6914.
[88] Ferreira, E. O.; Salvador, M. J.; Pral, E. M. F.; Alfieri, S. C.; Ito, I.
Y.; Dias, D. A. A new heptasubstituted (E)-aurone glucoside and
other aromatic compounds of Gomphrena agrestis with biological
activity. Zeitschrift Fur Naturforschung C-a Journal of
Biosciences, 2004, 59(7-8), 499-505.
[89] Erazo, S.; Rocco, G.; Zaldivar, M.; Delporte, C.; Backhouse, N.;
Castro, C.; Belmonte, E.; Delle Monache, F.; Garcia, R. Active
metabolites from Dunalia spinosa resinous exudates. Zeitschrift Fur
Naturforschung Section C-a Journal of Biosciences, 2008, 63(7-8),
492-496.
[90] Kumar, V.; Rani, A.; Dixit, A. K.; Pratap, D.; Bhatnagar, D. A
comparative assessment of total phenolic content, ferric reducing-
anti-oxidative power, free radical-scavenging activity, vitamin C
and isoflavones content in soybean with varying seed coat colour.
Food Research International, 2010, 43(1), 323-328.
148 Current Medicinal Chemistry, 2015, Vol. 22, No. 1
[91] Oldoni, T. L. C.; Cabral, I. S. R.; d’Arce, M. A. B. R.; Rosalen, P.
L.; Ikegaki, M.; Nascimento, A. M.; Alencar, S. M. Isolation and
analysis of bioactive isoflavonoids and chalcone from a new type
of Brazilian propolis. Sep. Purif. Technol., 2011, 77(2), 208-213.
[92] Tunon, M. J.; Garcia-Mediavilla, M. V.; Sanchez-Campos, S.;
Gonzalez-Gallego, J. Potential of Flavonoids as Anti-inflammatory
Agents: Modulation of Pro- Inflammatory Gene Expression and
Signal Transduction Pathways. Current Drug Metabolism, 2009,
10(3), 256-271.
[93] Botta, B.; Menendez, P.; Zappia, G.; de Lima, R. A.; Torge, R.;
Delle Monache, G. Prenylated Isoflavonoids: Botanical
Distribution, Structures, Biological Activities and Biotechnological
Studies. An Update (1995-2006). Curr. Med. Chem., 2009, 16(26),
3414-3468.
[94] Mukne, A. P.; Viswanathan, V.; Phadatare, A. G. Structure pre-
requisites for isoflavones as effective antibacterial agents.
Pharmacognosy reviews, 2011, 5(9), 13-8.
[95] Mahabusarakam, W.; Deachathai, S.; Phongpaichit, S.; Jansakul,
C.; Taylor, W. C. A benzil and isoflavone derivatives from Derris
scandens Benth. Phytochemistry, 2004, 65(8), 1185-1191.
[96] He, J.; Chen, L.; Heber, D.; Shi, W.; Lu, Q.-Y. Antibacterial
Compounds from Glycyrrhiza uralensis. J. Nat. Prod., 2006, 69(1),
121-124.
[97] Chacha, M.; Bojase-Moleta, G.; Majinda, R. R. T. Antimicrobial
and radical scavenging flavonoids from the stem wood of Erythrina
latissima. Phytochemistry, 2005, 66(1), 99-104.
[98] Gumula, I.; Heydenreich, M.; Derese, S.; Ndiege, I. O.; Yenesew,
A. Four isoflavanones from the stem bark of Platycelphium voense.
Phytochem. Lett., 2012, 5(1), 150-154.
[99] Gupta, V. K.; Fatima, A.; Faridi, U.; Negi, A. S.; Shanker, K.;
Kumar, J. K.; Rahuja, N.; Luqman, S.; Sisodia, B. S.; Saikia, D.;
Darokar, M. P.; Khanuja, S. P. S. Antimicrobial potential of
Glycyrrhiza glabra roots. J. Ethnopharmacol., 2008, 116(2), 377-
380.
[100] Rukachaisirikul, T.; Innok, P.; Aroonrerk, N.; Boonamnuaylap, W.;
Limrangsun, S.; Boonyon, C.; Woonjina, U.; Suksamrarn, A.
Antibacterial pterocarpans from Erythrina subumbrans. J.
Ethnopharmacol., 2007, 110(1), 171-175.
[101] Tanaka, H.; Hirata, M.; Etoh, H.; Sako, M.; Sato, M.; Murata, J.;
Murata, H.; Darnaedi, D.; Fukai, T. Four new isoflavonoids and a
new 2-arylbenzofuran from the roots of Erythrina variegata.
Heterocycles, 2003, 60(12), 2767-+.
[102] Majumdar, S.; Srirangam, R. Potential of the bioflavonoids in the
prevention/treatment of ocular disorders. Journal of Pharmacy and
Pharmacology, 2010, 62(8), 951-965.
[103] Anagnostopoulou, M. A.; Kefalas, P. Bioflavonoid profile of citrus
juices from Greece. Biomedical Chromatography, 2012, 26(10),
1252-1268.
[104] Mbukwa, E.; Chacha, M.; Majinda, R. R. T. Phytochemical
constituents of Vangueria infausta: their radical scavenging and
antimicrobial activities. Arkivoc, 2007, 104-112.
[105] Deng, Y. H.; Lee, J. P.; Tianasoa-Ramamonjy, M.; Snyder, J. K.;
Des Etages, S. A.; Kanada, D.; Snyder, M. P.; Turner, C. J. New
antimicrobial flavanones from Physena madagascariensis. J. Nat.
Prod., 2000, 63(8), 1082-1089.
[106] Cazarolli, L. H.; Zanatta, L.; Alberton, E. H.; Reis Bonorino
Figueiredo, M. S.; Folador, P.; Damazio, R. G.; Pizzolatti, M. G.;
Mena Barreto Silva, F. R. Flavonoids: Prospective Drug
Candidates. Mini-Rev. Med. Chem., 2008, 8(13), 1429-1440.
[107] Zhong, L. Y.; Zhou, L. G.; Zhou, Y. M.; Chen, Y. Q.; Sui, P.;
Wang, J. G.; Wang, M. G. Antimicrobial flavonoids from the twigs
of Populus nigra x Populus deltoides. Nat. Prod. Res., 2012, 26(4),
307-313.
[108] Wu, T.; Zang, X. X.; He, M. Y.; Pan, S. Y.; Xu, X. Y. Structure-
Activity Relationship of Flavonoids on Their Anti-Escherichia coli
Activity and Inhibition of DNA Gyrase. J. Agric. Food Chem.,
2013, 61(34), 8185-8190.
[109] Xiao, J. B.; Kai, G. Y. A Review of Dietary Polyphenol-Plasma
Protein Interactions: Characterization, Influence on the Bioactivity,
and Structure-Affinity Relationship. Critical Reviews in Food
Science and Nutrition, 2012, 52(1-3), 85-101.
[110] Cao, H.; Chen, X. Q. Structures Required of Flavonoids for
Inhibiting Digestive Enzymes. Anti-Cancer Agents in Medicinal
Chemistry, 2012, 12(8), 929-939.
Xie et al.
[111] Xiao, J.; Kai, G.; Yamamoto, K.; Chen, X. Advance in Dietary
Polyphenols as
-Glucosidases Inhibitors: A Review on Structure-
Activity Relationship Aspect. Critical Reviews in Food Science
and Nutrition, 2013, 53(8), 818-836.
[112] Ulanowska, K.; Tkaczyk, A.; Konopa, G.; Wegrzyn, G. Differential
antibacterial activity of genistein arising from global inhibition of
DNA, RNA and protein synthesis in some bacterial strains. Arch.
Microbiol., 2006, 184(5), 271-278.
[113] Cushnie, T. P. T.; Lamb, A. J. Detection of galangin-induced
cytoplasmic membrane damage in Staphylococcus aureus by
measuring potassium loss. J. Ethnopharmacol., 2005, 101(1-3),
243-248.
[114] Eumkeb, G.; Chukrathok, S. Synergistic activity and mechanism of
action of ceftazidime and apigenin combination against
ceftazidime-resistant Enterobacter cloacae. Phytomedicine, 2013,
20(3-4), 262-269.
[115] Verghese, J.; Thuy, N.; Oppegard, L. M.; Seivert, L. M.; Hiasa, H.;
Ellis, K. C. Flavone-based analogues inspired by the natural
product simocyclinone D8 as DNA gyrase inhibitors. Bioorg. Med.
Chem. Lett., 2013, 23(21), 5874-5877.
[116] Nakayama, M.; Shimatani, K.; Ozawa, T.; Shigemune, N.;
Tsugukuni, T.; Tomiyama, D.; Kurahachi, M.; Nonaka, A.;
Miyamoto, T. A study of the antibacterial mechanism of catechins:
Isolation and identification of Escherichia coli cell surface proteins
that interact with epigallocatechin gallate. Food Control, 2013,
33(2), 433-439.
[117] Wang, Y.; Lee, S. M.; Dykes, G. A. Potential mechanisms for the
effects of tea extracts on the attachment, biofilm formation and cell
size of Streptococcus mutans. Biofouling, 2013, 29(3), 307-318.
[118] Groblacher, B.; Kunert, O.; Bucar, F. Compounds of Alpinia
katsumadai as potential efflux inhibitors in Mycobacterium
smegmatis. Bioorg. Med. Chem., 2012, 20(8), 2701-2706.
[119] Dey, D.; Debnath, S.; Hazra, S.; Ghosh, S.; Ray, R.; Hazra, B.
Pomegranate pericarp extract enhances the antibacterial activity of
ciprofloxacin against extended-spectrum beta-lactamase (ESBL)
and metallo-beta-lactamase (MBL) producing Gram-negative
bacilli. Food Chem. Toxicol., 2012, 50(12), 4302-4309.
[120] Asha, M. K.; Debraj, D.; Prashanth, D.; Edwin, J. R.; Srikanth, H.
S.; Muruganantham, N.; Dethe, S. M.; Anirban, B.; Jaya, B.;
Deepak, M.; Agarwal, A. In vitro anti-Helicobacter pylori activity
of a flavonoid rich extract of Glycyrrhiza glabra and its probable
mechanisms of action. J. Ethnopharmacol., 2013, 145(2), 581-586.
[121] Paolillo, R.; Carratelli, C. R.; Rizzo, A. Effect of resveratrol and
quercetin in experimental infection by Salmonella enterica serovar
Typhimurium. Int. Immunopharmacol., 2011, 11(2), 149-156.
[122] Feldman, M.; Santos, J.; Grenier, D. Comparative Evaluation of
Two Structurally Related Flavonoids, Isoliquiritigenin and
Liquiritigenin, for Their Oral Infection Therapeutic Potential. J.
Nat. Prod., 2011, 74(9), 1862-1867.
[123] Vandeputte, O. M.; Kiendrebeogo, M.; Rasamiravaka, T.;
Stevigny, C.; Duez, P.; Rajaonson, S.; Diallo, B.; Mol, A.;
Baucher, M.; El Jaziri, M. The flavanone naringenin reduces the
production of quorum sensing-controlled virulence factors in
Pseudomonas aeruginosa PAO1. Microbiology-(UK), 2011, 157,
2120-2132.
[124] Wang, Y.; Curtis-Long, M. J.; Yuk, H. J.; Kim, D. W.; Tan, X. F.;
Park, K. H. Bacterial neuraminidase inhibitory effects of prenylated
isoflavones from roots of Flemingia philippinensis. Bioorg. Med.
Chem., 2013, 21(21), 6398-6404.
[125] Zu, Y. G.; Liu, X. L.; Fu, Y. J.; Wu, N.; Kong, Y.; Wink, M.
Chemical composition of the SFE-CO2 extracts from Cajanus cajan
(L.) Huth and their antimicrobial activity in vitro and in vivo.
Phytomedicine, 2010, 17(14), 1095-1101.
[126] Tormakangas, L.; Vuorela, P.; Saario, E.; Leinonen, M.; Saikku, P.;
Vuorela, H. In vivo treatment of acute Chlamydia pneumoniae
infection with the flavonoids quercetin and luteolin and an alkyl
gallate, octyl gallate, in a mouse model. Biochem. Pharmacol.,
2005, 70(8), 1222-1230.
[127] French, G. L. The continuing crisis in antibiotic resistance. Int. J.
Antimicrob. Agents, 2010, 36, S3-S7.
[128] Guz, N. R.; Stermitz, F. R.; Johnson, J. B.; Beeson, T. D.; Willen,
S.; Hsiang, J.-F.; Lewis, K. Flavonolignan and Flavone Inhibitors
of a Staphylococcus aureus Multidrug Resistance Pump:
 Antibacterial Activities of Flavonoids Current Medicinal Chemistry, 2015, Vol. 22, No. 1 149

Structure
Activity Relationships. Journal of Medicinal Chemistry, Flavonoids Isolated from the Roots of Sophora flavescens. Arch.
2000, 44(2), 261-268. Pharm. Res., 2011, 34(2), 217-222.
[129] Schutz, B. A.; Wright, A. D.; Rali, T.; Sticher, O. Prenylated [132] Inui, S.; Hosoya, T.; Shimamura, Y.; Masuda, S.; Ogawa, T.;
flavanones from leaves of macaranga-pleiostemona. Kobayashi, H.; Shirafuji, K.; Moli, R. T.; Kozone, I.; Shin-ya, K.;
Phytochemistry, 1995, 40(4), 1273-1277. Kumazawa, S. Solophenols B-D and Solomonin: New Prenylated
[130] Xu, Q. H.; Li, J. Z.; He, J. H.; Zhao, X.; Huo, Q. S. Synthesis of Polyphenols Isolated from Propolis Collected from The Solomon
novel flavanone derivatives and their anti Staphylococcus aureus Islands and Their Antibacterial Activity. J. Agric. Food Chem.,
evaluation. Chemical Research in Chinese Universities, 2013, 2012, 60(47), 11765-11770.
29(4), 695-698. [133] Alarcon, R.; Flores, R.; Ocampos, S.; Lucatti, A.; Galleguillo, L.;
[131] Oh, I.; Yang, W. Y.; Chung, S. C.; Kim, T. Y.; Oh, K. B.; Shin, J. Tonn, C.; Sosa, V. Flavonoids from Pterocaulon alopecuroides with
In vitro Sortase A Inhibitory and Antimicrobial Activity of Antibacterial Activity. Planta Med., 2008, 74(12), 1463-1467.

Received: March 13, 2014 Revised: June 21, 2014 Accepted: June 21, 2014

View publication stats